Cardiovascular toxicities of BCR-ABL tyrosine kinase inhibitors in chronic myeloid leukemia: preventive strategies and cardiovascular surveillance

Aghel N, Delgado DH, Lipton JH

Vascular Health and Risk Management 2017, 13:293-303

Published Date: 4 August 2017